Entries by varshabi_oge7bw

Cannabis Use in Multiple Sclerosis

Patients with multiple sclerosis (MS) often seek complimentary treatments to alleviate their symptoms. According to the National Multiple Sclerosis Society, there is some evidence for the role of cannabis-based products as a complimentary alternative treatment for symptom management, although questions remain about the benefits relative to potential side effects. A new study characterizing the use […]

Safety and Efficacy of Cannabidiol for Treatment-Resistant Epilepsies

In honor of National Epilepsy Awareness Month, KannAInsight features new research on the potential benefits of cannabidiol for patients with treatment resistant epilepsy.  In approximately 1/3 of epileptic patients, medicines fail to control seizure activity. Since 2014, patients with severe treatment-resistant epilepsies have been receiving add-on cannabidiol (CBD) through Compassionate Use Programs, which provide access […]

Cannabis and COPD

It’s estimated that seniors are the fastest growing segment of the population using cannabis-based products. Indeed, a new survey showed that 45% of respondents over the age of 60 reported past-year marijuana use. Reasons for use included several medical issues, such as arthritis, back pain, anxiety, and more.  A recent large-scale study also looked at […]

Cannabis Use in Young Adult Cancer Patients

The American Cancer Society reports that more than 60,000 young adults are diagnosed with cancer each year in the United States, with about 4% of all cancers diagnosed in people ages 20-39. There are few studies on the prevalence of cannabis and cannabis-based products usage in cancer patients, but usage may be increasing, particularly in […]

Cannabinoids May Relieve Some Symptoms of Canine Osteoarthritis

According to the American Kennel Club (AKC), osteoarthritis (joint inflammation caused by deterioration of cartilage) is a common problem in dogs, particularly senior dogs and large breeds. Unfortunately, osteoarthritis is a progressive condition that is associated with pain and discomfort. Supplements and nonsteroidal anti-inflammatory drugs are often prescribed, but with continued use can produce side […]

Cannabinoids Show Benefits for Patients with Mental Illnesses

In 1990, Congress officially established the first full week of October as Mental Illness Awareness Week (MIAW). In honor of MIAW, KannAInsight highlights some newer research that examined whether cannabis/cannabinoid products might be a safe and effective treatment options for patients with mental illnesses. According to the National Alliance on Mental Health, approximately 1 in […]

Cannabidiol Shows Promise for Pediatric Movement Disorders

Complex movement disorders are neurological diseases that cause atypical movements and postures that interfere with a person’s desired movements. Children with these disorders might experience too much or too little movement or have coordination problems. Such abnormal movements and postures can be associated with chronic pain, orthopedic problems, feeding difficulties, sleep difficulties, and speech and […]

Cannabinoids for Palliative Care Symptoms

Palliative care is a resource for anyone living with a serious illness and can be helpful at any stage of illness. In addition to improving quality of life and helping with symptoms, palliative care can help patients understand their choices for medical treatment. Of late, some patients are opting for complimentary or alternative treatments to […]

More Than 10% of Americans Report Using CBD for Health Benefits

This week, KannAInsight highlights the results from Gallop’s most recent polling on cannabis sentiment and use (see results here, here, and here).  Approximately six in 10 Americans support marijuana legalization. For those individuals who do not favor legalization the most common reason was societal risks, including the possibility of increased car accidents involving drivers who […]

Cannabinoids for Patients with Alzheimer’s Disease

In honor of  World Alzheimer’s Month, KannAInsight features new research that suggests cannabinoids could help manage behavioral symptoms associated with Alzheimer’s Disease (AD).  According to the World Health Organization, there are approximately 50 million individuals worldwide suffering from dementia (including AD) and this number is increasing, with roughly 10 million new cases diagnosed each year. […]